Vaccines | Tenderlake

Vaccines

Contract Value:
EUR 99K - 99K
Notice Type:
Contract award notice
Published Date:
06 October 2023
Closing Date:
Location(s):
FI SUOMI / FINLAND (FI Finland/SUOMI / FINLAND)
Description:
Hepatitis A Vaccine (HAV) for children/adolescents and adults 2023 - 2025 (2025 - 2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) requested tenders for Hepatitis A Vaccine (HAV) belonging to the National Vaccination Programme in Finland.

The purpose of STM and the Customer was to procure Hepatitis A Vaccine (HAV) required for the National Vaccination Programme in Finland. The tendered vaccines must be suitable for children and adults.

More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare:

https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/hepatiittirokotteet/hepatiitti-a-rokote

The Customer will implement the procurement on behalf of STM.

Awarded to:
Hepatitis A Vaccine (HAV) for children/adolescents and adults 2023 - 2025 (2025 - 2027)
GlaxoSmithKline Oy, Helsinki (FI)
Download full details as .pdf
The Buyer:
Ministry of Social Affairs and Health
CPV Code(s):
33600000 - Pharmaceutical products
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33651600 - Vaccines